NAVILAS navigated laser therapy
Together with the recently obtained FDA approval for NAVILAS, OD-OS has now a great opportunity to launch its new product in Europe and United States. The new navigated laser system incorporates advanced imaging with retinal laser therapy in a planned and controlled way using image registration in one device with integrated workflow to support the safety, accuracy, speed, comfort and transparency of retina laser photocoagulation. Laser photocoagulation is the current standard in the treatment of many retinal disorders including Diabetic Retinopathy and Diabetic Macular Edema (DME).
NAVILAS®, allows physicians to move beyond conventional slit lamp based photocoagulation that provides only a partial slit image of the retina. The NAVILAS® system produces a live image of the fundus in true color, IR and red-free as well as fluorescein angiography (FA) with 50 degree field of view on a monitor – panable across the fundus. In contrast to fundus cameras or scanning laser ophthalmoscopes, this patented imaging technology is capable of real-time imaging of the retina in color – both mydriatic and non-mydriatic- while including a treatment laser to treat the retina.
"NAVILAS® means a new level regarding laser treatment application and integration with diagnostics. Moreover it is a necessary prerequisite towards improving treatment options", says Dr. Aljoscha Neubauer from the University Eye Clinic, Munich, Germany.
NAVILAS® made its first appearances in Germany in September at the Vitro -Retinal Symposium (VRS) in Frankfurt. Doctors were excited by the new technology that will, for the first time, allow them to use what we call Retina Navigation, the ability to IMAGE – PLAN – TREAT and DOCUMENT retina disorders", says Dr. Winfried Teiwes, CEO of OD-OS.
About OD-OS
OD-OS is an ISO 9001 and ISO 13485 certified medical device company headquartered in Teltow/Berlin, Germany. Its US operation, responsible for marketing, sales and support, is located Grapevine/Dallas, Texas.
OD-OS is a subsidiary of SensoMotoric Instruments (SMI), the technology leader in eye tracking and registration solutions for refractive laser surgery. Over the past 15 years, SMI has supplied technology to most major refractive laser manufacturers.
In 2008, after more than 4 years of development creating Retina Navigation within SMI, the core development team was spun-out into OD-OS and charged with resources and ophthalmic industry experts to bring Retina Navigation with its first product, NAVILAS®, to the market.
More information:
Hans Knubben
OD-OS GmbH
Warthestrasse 21
D-14513 Teltow / Germany
Phone: +49 (3328) 321 82 134
Fax: +49 (3328) 321 82 911
Email: hans.knubben@od-os.com
Internet: www.od-os.com
Kommentare von Besucher !
